Promoted interaction of nuclear factor-κB with demethylated cystathionine-β-synthetase gene contributes to gastric hypersensitivity in diabetic rats

J Neurosci. 2013 May 22;33(21):9028-38. doi: 10.1523/JNEUROSCI.1068-13.2013.

Abstract

Patients with long-standing diabetes frequently demonstrate gastric hypersensitivity with an unknown mechanism. The present study was designed to investigate roles for nuclear factor-κB (NF-κB) and the endogenous H2S-producing enzyme cystathionine-β-synthetase (CBS) signaling pathways by examining cbs gene methylation status in adult rats with diabetes. Intraperitoneal injection of streptozotocin (STZ) produced gastric hypersensitivity in female rats in response to gastric balloon distention. Treatment with the CBS inhibitor aminooxyacetic acid significantly attenuated STZ-induced gastric hypersensitivity in a dose-dependent fashion. Aminooxyacetic acid treatment also reversed hyperexcitability of gastric-specific dorsal root ganglion (DRG) neurons labeled by the dye DiI in diabetic rats. Conversely, the H2S donor NaHS enhanced neuronal excitability of gastric DRG neurons. Expression of CBS and p65 were markedly enhanced in gastric DRGs in diabetic rats. Blockade of NF-κB signaling using pyrrolidine dithiocarbamate reversed the upregulation of CBS expression. Interestingly, STZ treatment led to a significant demethylation of CpG islands in the cbs gene promoter region, as determined by methylation-specific PCR and bisulfite sequencing. STZ treatment also remarkably downregulated the expression of DNA methyltransferase 3a and 3b. More importantly, STZ treatment significantly enhanced the ability of cbs to bind DNA at the p65 consensus site, as shown by chromatin immunoprecipitation assays. Our findings suggest that upregulation of cbs expression is attributed to cbs promoter DNA demethylation and p65 activation and that the enhanced interaction of the cbs gene and p65 contributes to gastric hypersensitivity in diabetes. This finding may guide the development and evaluation of new treatment modalities for patients with diabetic gastric hypersensitivity.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids
  • Analysis of Variance
  • Animals
  • Area Under Curve
  • Case-Control Studies
  • Chromatin Immunoprecipitation
  • CpG Islands / drug effects
  • CpG Islands / physiology
  • Cystathionine beta-Synthase / genetics
  • Cystathionine beta-Synthase / metabolism*
  • DNA (Cytosine-5-)-Methyltransferases / genetics
  • DNA (Cytosine-5-)-Methyltransferases / metabolism
  • DNA Methyltransferase 3A
  • DNA Methyltransferase 3B
  • Diabetes Mellitus, Experimental / complications*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Electromyography
  • Enzyme Inhibitors / pharmacology
  • Female
  • Ganglia, Spinal / pathology
  • Hypersensitivity* / drug therapy
  • Hypersensitivity* / etiology
  • Membrane Potentials / drug effects
  • Methylation / drug effects
  • NF-kappa B / metabolism*
  • Neoplasm Proteins / metabolism
  • Nucleocytoplasmic Transport Proteins / metabolism
  • Oxamic Acid / therapeutic use
  • Patch-Clamp Techniques
  • Rats
  • Rats, Sprague-Dawley
  • Sensory Receptor Cells / drug effects
  • Sensory Receptor Cells / physiology
  • Stomach Diseases / drug therapy
  • Stomach Diseases / etiology*
  • Sulfites / pharmacology
  • Up-Regulation / drug effects

Substances

  • Amino Acids
  • Enzyme Inhibitors
  • NF-kappa B
  • Neoplasm Proteins
  • Nucleocytoplasmic Transport Proteins
  • Sulfites
  • dolaisoleucine
  • p65 oncofetal mRNA transport protein, rat
  • sodium hydrogen sulfite
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA Methyltransferase 3A
  • Cystathionine beta-Synthase
  • Oxamic Acid